Supplemental Text and Figures

Fig. S1 Structural analysis of SecA dimers, related to Figures 1 and 2.
A. All the available crystal contacts from dimeric SecA structures with resolution better than 3Å and R free ≤ 30% were re-examined using EPPIC (Duarte et al., 2010) .
Runs were carried out in September 2012 using Uniprot 2012_07. Summary view of EPPIC interface analysis for entries 1NL3_1
(interface 1 in the lattice) (M. tuberculosis) (Sharma et al., 2003) and 1M6N (B. subtilis) (Hunt et al., 2002) .
Columns from left to right In the 1NL3_1 structure, a 15-residue extension of the aminoterminus, that replaced α0 during cloning, contributes to the interface. In the 1M6N structure (Ding et al., 2003; Hunt et al., 2002) part of α0 and the preceding N-terminus of one protomer participate in crystal contacts with the other protomer, in a fashion similar to that of the 1NL3_1 interface. Superimposing protomers A of the two dimers, reveals that residues Ile4 in 1M6N and Leu11 of the engineered 1NL3_1 extension occupy the same spatial position and fulfill the same role in the dimerization interface. We presume that the 1NL3_1 engineered extension partly mimics the interaction seen around Ile4 in the 1M6N structure (corresponding to Leu5 in the ecSecA sequence and Leu2 in the mtSecA sequence).
B.
Testing the E.coli SecA intercalated dimer by engineered cysteines. Left: In the dimeric ecSecA (Papanikolau et al., 2007) one protomer is colored (NBD=dark blue;
IRA2=light blue) and the other is depicted with a transparent grey color. Residues mutated to cysteines are indicated with red spheres in the colored protomer. Right:
The colored protomer has undergone a ~90º rotation with respect to the y-axis. Mass measurements of the oxidized proteins are presented in Table S2 . 2FSF; residues 9-419) was structurally aligned with the corresponding domain from the helicases Vasa (PDB: 2DB3) (Sengoku and Wagatsuma, 2006) and eF4A (PDB: 1FUU) (Caruthers et al., 2000) . Structures are shown in the same orientation to highlight differences. The three N-terminal SecA helices (ribbon representation; yellow) differ significantly from the corresponding regions of other Superfamily 2 (SF2) helicases. The linker connecting to the second RecA fold domain (i.e. IRA2 in SecA) is shown in light blue. Helix α0 of ecSecA, not present in the crystallized protein, (Papanikolau et al., 2007) is shown schematically. Its location was identified after structural modeling using PDB: 1NL3_1 [see Fig. S2 ; (Sharma et al., 2003) ] and a combination of secondary structure prediction and CLUSTALW alignment on the PBIL server (http://npsa-pbil.ibcp.fr/cgibin/npsa_automat.pl?page=/NPSA/npsa_clustalw.html).
D.
Sequence alignment and secondary structure features of the SecA N-terminal region. A schematic representation of the SecA amino-termini is shown as determined from various crystal structures; E.coli (PDB: 2FSF) (Papanikolau et al., 2007) ; T.thermophilus (PDB: 2IPC) (Vassylyev et al., 2006) ; M.tuberculosis, (PDB:
1NL3; SecA1) (Sharma et al., 2003) ; B.subtilis (SecA_BSUB_1; PDB: 1M6N) (Ding et al., 2003) , (SecA_BSUB_2; PDB: 1TF5) (Osborne et al., 2004) and (SecA_BSUB_3; PDB: 2BIM) (Zimmer et al., 2006) and T.maritima (PDB: 3DIN) (Zimmer et al., 2008) .
Dotted lines indicate unresolved parts of the structure.
Secondary structure prediction algorithms propose helix α0 to exist in most SecA sequences, while it is absent from others as seen in the alignment below:
Symbols used: c= coil, h= α-helix, e= β-strand: Cons.
Secondary structure predictions were carried out using CLUSTALW on the PBIL server. Ten algorithms were used to derive the consensus sequence [DSC (King and Sternberg, 1996) , DPM (Deleage and Roux, 1987) , GOR I (Garnier et al., 1978) , GOR III (Gibrat et al., 1987) , GOR IV (Garnier et al., 1996) , HNN (Guermeur, 1997), SIMPA96 (Levin et al., 1996) , PHD (Rost et al., 1994) , PREDATOR (Argos et al., 1996) , SOPM (Geourjon and Deleage, 1994) E. Schematic maps of SecA derivatives used in this study with either truncation of the N-terminal decapentapeptide and/or 6 alanyl point substitutions in α1 (indicated with "6A".). Sequence alignment of SecAs reveals conservation at the level of the physicochemical properties of the N-terminal residues (CLUSTALW alignment server, PBIL France). Light blue color indicates >70% conservation, while grey color indicates >50% conservation. Data were derived from a comparison of 50 SecA sequences. SecA(GH) has a Gly-His N-terminal extension before the 1-901 SecA sequence, as a result of cleaving the purified His 6 -linker-TEV site-SecA protein with the TEV (Tobacco Etch Virus) protease. Red highlights the region that is found to participate in dimerization contacts in the dimeric structures (Fig. 1C) . A. Monomeric SecA(Δα0/α1-6A) was tested for dimerization at higher concentrations than allowed by our analytical GPC-MALLS system (upper limit of ~8µM at the chromatographic peak) by using preparative GPC (50mM Table S2 . For the experiments below we used SecA that carries the indigenous Cys98
(next to helix α1) as the only cysteinyl residue, following removal of the C-terminal tail. This was to avoid interference from 3 cysteines present in the C-tail.
A. SecA Urea was used in order to fully dissociate the non-covalent dimers into monomers (single circle). Fractions were analyzed on non-reducing SDS-PAGE (7.5%) and those containing the covalent dimer (lanes 3-5; double circle linked with red bar) were pooled, concentrated and re-fractionated, in 50mM Tris-HCl pH=8.0, 50mM NaCl The two biologically relevant SecA dimerization interfaces (1M6N, 1NL3_1) predicted with EPPIC (see Fig. S1A ) were further inspected. To this end, the ecSecA sequence was modeled into these two dimeric structures, and the contact interfaces were analyzed in the PIC (Protein Interaction Calculator) server (Tina et al., 2007 Fig. S3 . Values were determined as described in the Supplemental Experimental Procedures.
Supplemental movies
Supplemental movie S1, related to Figure 1B .
Transition from the 1M6N bsSecA dimer (Hunt et al., 2002) to the 1NL3_1 mtSecA dimer (Fig. S1A) . In all cases ecSecA models of the structures were used (see legend Superimposition of the ecSecA 1M6N modeled structure onto the ecSecA 1NL3_1 modeled structure.
The two biologically relevant SecA dimers (1NL3_1, 1M6N) predicted by EPPIC (see Fig. S1 ) were further inspected. To this end, the ecSecA sequence was modeled onto these two dimeric structures by using SwissModel (Kiefer et al., 2009 ) assembling the dimers in Coot (Emsley et al., 2010) and minimizing the resulting models with Refmac5 (Murshudov et al., 2011) . A PDB file is displaying the superimposition based on chain A of the SecA dimer found in the crystal structure of PDB entry 1M6N (B. subtilis) onto the 1NL3_1 dimer described above. Structures appear in cartoon mode with 1NL3_1 in blue and 1M6N in magenta. See also corresponding Supplemental Movie S1 displaying a model of the transition from between these dimers.
Supplemental Experimental Procedures
Plasmids and strains: are described below or, previously (Baud et al., 2002; Gouridis et al., 2009; Jarosik and Oliver, 1991; Karamanou et al., 1999; Keramisanou et al., 2006; Papanikou et al., 2004; Sianidis et al., 2001; Vrontou et al., 2004) His 6 SecA(Y134C/6-901), His 6 SecA(H484C/6-901) and His 6 SecA(A488C/6-901)
were constructed by "megaprimer" PCR using pIMBB7 [His 6 SecA(6-901) as template.
For His 6 SecA(Y134C/6-901), X284 (5' CC GTC AAC GAC TGC CTG GCG CAA CG 3'; mutagenic forward) and X278 (5' G TTT ATA CAT TTC CGA GCT GTC TTC 3'; reverse) were used as primers. This PCR product was used in a second step with X279 (5' ACG ACT CAC TAT AGG GAG ACC ACA ACG 3') as forward primer. The
BclI/BamHI fragment of the final PCR product replaced the corresponding one in pIMBB7, resulting in pIMBB522.
For His 6 SecA(H484C/6-901), X317 (5' CGC TTC GTT GGC GCA GAA TTT GGC GTT 3'; mutagenic reverse) and X272 (5' C TAC AAG CTG GAT ACC GTC GTT GTT 3'; forward) were used as primers. This PCR product was used in a second step with X273 (5'CTG ACG ACC AGA ACG ACC GCG CAA CTG 3') as forward primer. The BglII/KpnI fragment of the final PCR product replaced the corresponding one in pIMBB7, resulting in pIMBB577.
For His 6 SecA(A488C/6-901), X320 (5' G AGC AAC AAT CGC GCA TTC GTT GGC GTG GAA TTT 3'; mutagenic reverse) and X272 (5' C TAC AAG CTG GAT ACC GTC GTT GTT 3'; forward) were used as primers. This PCR product was used in a second step with X273 (5' CTG ACG ACC AGA ACG ACC GCG CAA CTG 3') as reverse primer. The BglII/KpnI fragment of the final PCR product replaced the corresponding one in pIMBB7, resulting in pIMBB575.
His 6 SecA-Cys -(Y134C/6-901) was constructed by "megaprimer" PCR using pIMBB258 (His 6 SecA-Cys-) as template, X284 (5' CC GTC AAC GAC TGC CTG GCG CAA CG 3'; mutagenic forward) and X278 (5' G TTT ATA CAT TTC CGA GCT GTC TTC 3'; reverse) as primers. This product was used in a second PCR step with X279 (5' ACG ACT CAC TAT AGG GAG ACC ACA ACG 3') as forward primer. The
BclI/BamHI fragment of the final PCR product replaced the corresponding one in pIMBB258, resulting in pIMBB642.
His 6 SecA-Cys -(H484C/6-901) and His 6 SecA-Cys -(A488C/6-901) were constructed by replacing the 0.413kbp BglII/KpnI restriction fragment of pIMBB258
with the corresponding one from pIMBB577 or pIMBB575, resulting in pIMBB584 and pIMBB857 respectively.
His 6 SecA-Cys -(Y134C/H484C/6-901) was constructed by replacing the 0.88kbp BclI/BamHI restriction fragment of pIMBB584 with the corresponding one from pIMBB642, resulting in pIMBB859.
His 6 SecA-Cys -(Y134C/A488C/6-901) was constructed by replacing the 0.886kbp BclI/BamHI restriction fragment of pIMBB857 with the corresponding one from pIMBB642, resulting in pIMBB858.
His 6 SecA(Y134S/6-901) was constructed by "megaprimer" PCR using pIMBB7 For in vivo secretion experiments, preprotein genes were cloned under the control of an arabinose promoter, using pBAD33.
proPhoA-his was constructed by PCR, using pIMBB882 as template, X629 concentrated, dialyzed (in 50mM Tris-HCl pH:8.0; 50mM KCl; 50% glycerol) and stored at -80ºC. In the case of SecA(Δα0/α1-6A) only monomeric SecA was purified in the last gel filtration step.
The "ED state" SecA was purified as a monomer in the first gel filtration step (1M KCl) and a dimer in the second gel filtration step (50mM KCl). The "SRD state"
was purified as a dimer in both gel filtration steps. The "monomer state" was purified as a monomer in both gel filtration steps. The "TD state" (SecA/PrlD23) was purified as the "ED state" (see above). GPC-MALLS/QELS (see also Fig.2A ).
Multi-angle laser light scattering (MALLS) and
nES-GEMMA:
A nanoelectrospray instrument coupled to a gas-phase electrophoretic mobility molecular analyzer (nES-GEMMA) with a condensation particle counter Island, NY), whereas the ion mobility spectrometer used for the GEMMA separation was a differential mobility analyzer (TSI Inc., macroIMS, Series 3080C). Detection was achieved using a butanol-based Ultrafine CPC (TSI Inc., Series 3025A). IMS version 2.0.1.0 software (TSI Inc.) was used for data acquisition and data analysis.
Sample solutions in Eppendorf tubes were placed into the nES unit as described (Kapellios et al., 2011) and were analyzed with a nES flow rate of ~70 nL min -1 . Preparation of SecYEG-IMVs: was as described (Lill et al., 1990; Rhoads et al., 1984; Yamada et al., 1989) , from cells overexpressing a wild type (van der Does et al., 1996) or, a PrlA4 secYEG operon. To obtain unilamellar vesicles the IMVs suspension was manually extruded through a polycarbonate membrane (Avestin Inc, LiposoFast). Reactions were stopped by adding 10% (v/v) of buffer X (1 volume 0.5M EDTA pH8, 4 volumes 2.5M K 2 HPO 4 ) and (1% v/v) TX-100. Cell debris were removed by centrifugation (17,000xg; 4min) and absorbance was measured at 420nm. Alkaline phosphatase units were calculated (Derman et al., 1993) and then converted to mass of secreted protein by using a standard curve of the phosphate released by known amounts of purified PhoA. Secretion by chromosomal SecYEG or SecA under the same conditions was measured (using empty pET610 or pASK plasmids) and subtracted.
Calculation of activation energies (E
In vitro translocation of proPhoA: Translocation was performed in 100µl reactions (50mM Tris-HCl pH:8.0, 50mM KCl, 5mM MgCl 2 , 0.5mg ml -1 BSA, 1mM DTT, ATP (2.5-10mM; as indicated), SecA or derivatives (0.4 or as indicated), SecYEG IMVs or derivatives (1µM SecY; or as indicated) and proPhoA (8µM; or as indicated).
Reactions were incubated (37ºC; 12min; or as indicated) and translocation of proteins into the lumen of the IMVs was terminated by addition of proteinase K (1mg ml -1 , 20-60min; or as indicated, 4ºC). Proteins were precipitated with trichloroacetic acid (TCA; 15% w/v), analyzed by SDS-PAGE (13% acrylamide) together with known amounts of purified proPhoA-his and immunostained with α-proPhoA antisera.
Chemiluminescent signals were visualized with a CCD-imager (LAS-3000; Fujifilm) and measured using Image J software (Wayne Rasband; NIH). Translocated immunostained material was transformed to protein mass using standard curves of purified proPhoA-his immunostained on the same blots. The standard curves were also used to ensure that in all the experiments the translocated material was in the linear range (R 2 ≥ 0.95).
Trapping of the polypeptide chain in the translocase holoenzyme: Procedure accomplished as previously described (Gouridis et al., 2009) 
77). The in vivo
SecA secretion values are also linearly correlated to the calculated intracellular concentration, up to 60µM, at which the remaining secretion activity is approximately 15% (y=-1.83x + 107.65, R 2 =0.98). From these two equations, the concentration at which the remaining activity would be 50%; is calculated to be 75µM (for the in vitro (=75/31). We interpret this difference as suggesting that the effective in vivo concentration is ~2.4 times than what is nominally calculated. We attribute this difference to poorly understood in vivo parameters such as macromolecular crowding, biased sub-cellular protein topologies and lower actual available water volume available for macromolecular diffusion (Minton, 2006; Zimmerman and Trach, 1991) . Both data-sets permitted observation of proPhoA secretion as a function of SecA concentration at the full concentration and secretion range (Fig. 5E ). 
Intracellular concentration of
